Comparative Receptor Surface Analysis (CoRSA) Model for Calcium Channel Antagonists

Abstract Three-dimensional quantitative structure-activity relationships (3D QSAR) are widely used for the prediction of in vitro or in vivo interactions between chemical compounds and their biological targets (transporters, receptors, ion channels, enzymes). Comparative receptor surface analysis (CoRSA) is a new 3D QSAR algorithm that can be applied to study ligand-receptor interactions whenever the structure of the biological target is not known. The steric and electrostatic features of the most active compounds from a QSAR set are used by CoRSA to generate a virtual receptor model, represented as points on a surface complementary to the van der Waals surface of the aligned compounds. The CoRSA structural descriptors, represented by the total interaction energies between each surface point of the virtual receptor and all atoms in a molecule, are used in a partial least squares data analysis to generate a structure-activity model. In this paper the calcium channel antagonist activity of 35 dihydropyridine derivatives is modeled with CoRSA, giving a 3D QSAR with r 2=0.928 for calibration and r cv 2 = 0.921 for the leave-one-out cross-validation.

[3]  H. Kubinyi.  QSAR and 3D QSAR in drug design Part 1: methodology , 1997 .

[4]  G. Cruciani,et al.  Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. , 1994, Journal of medicinal chemistry.

[6]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[7]  Jordi Mestres,et al.  A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors , 1999, J. Comput. Aided Mol. Des..

[8]  Kimito Funatsu,et al.  GA Strategy for Variable Selection in QSAR Studies: GA-Based PLS Analysis of Calcium Channel Antagonists , 1997, J. Chem. Inf. Comput. Sci..

[9]  Elaine C. Meng,et al.  Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities , 1994, J. Comput. Aided Mol. Des..

[10]  O. Ivanciuc.  3D QSAR Models , 2001 .

[11]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[12]  Anton J. Hopfinger,et al.  A 3D-QSAR Study of Anticoccidial Triazines Using Molecular Shape Analysis , 1995, J. Chem. Inf. Comput. Sci..

[13]  O. Ivanciuc,et al.  Matrices and Structural Descriptors Computed from Molecular Graph Distances , 2000 .

[14]  D. Rogers,et al.  Receptor surface models. 2. Application to quantitative structure-activity relationships studies. , 1995, Journal of medicinal chemistry.

[15]  Matthew Clark,et al.  Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases , 1990 .

[16]  A. Balaban,et al.  Vertex- and Edge-Weighted Molecular Graphs and Derived Structural Descriptors , 2000 .

[17]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[18]  W. Richards,et al.  Self-organizing molecular field analysis: a tool for structure-activity studies. , 1999, Journal of medicinal chemistry.

[19]  C. Hansch.  Quantitative approach to biochemical structure-activity relationships , 1969 .

[20]  Mathew Hahn,et al.  Receptor Surface Models , 1998 .

[21]  Y. Takahata,et al.  Quantitative Structure-Activity Relationships for 1,4-Dihydropyridine Calcium Channel Antagonists (Nifedipine Analogues): A Quantum ChemicalKlassical Approach , 1994 .

[22]  H. Kubinyi.  QSAR and 3D QSAR in drug design Part 2: applications and problems , 1997 .

[23]  O. Balaban.  The Graph Description of Chemical Structures , 2000 .

[24]  H. Kubinyi.  Comparative Molecular Field Analysis (CoMFA) , 2002 .

[25]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[26]  M. Hahn.  Receptor surface models. 1. Definition and construction. , 1995, Journal of medicinal chemistry.